Asia-Pacific Americas Africa Europe Middle East

PT ETANA BIOTECHNOLOGIES INDONESIA

Company Profile:

PT ETANA BIOTECHNOLOGIES INDONESIA Company Introduction

Company Type: Manufacturer (Factory)

PT Etana Biotechnologies Indonesia is a leading biopharmaceutical company based in Indonesia, dedicated to the research, development, and manufacturing of high-quality biotechnological products. The company specializes in producing vaccines, biopharmaceuticals, and other innovative healthcare solutions. Etana Biotechnologies operates its own state-of-the-art manufacturing facilities, enabling it to produce essential and advanced pharmaceutical products that meet international standards. Through its commitment to scientific excellence and production capabilities, PT Etana Biotechnologies Indonesia plays a significant role in improving public health and contributing to the advancement of the healthcare sector in Indonesia and the wider region.

Enterprise Products

PT Etana Biotechnologies Indonesia produces and/or sells the following products:

* Erythropoietin (Epoetin alfa)

* Filgrastim

* Pegfilgrastim

* Insulin Glargine

* Bevacizumab

* Biosimilar products

* COVID-19 vaccine (mRNA-based)

* Other biopharmaceutical products

Business Registration Information:

Manager:

Dr. Nathaniel A. Viuniski (President Director)
Phone:

+62 21 6530 0899
E-mail:

info@etanabio.co.id
Official Website:
Address:

Jl. Yos Sudarso Kav. 89, Sunter Jaya, Tanjung Priok, Jakarta Utara, DKI Jakarta 14350, Indonesia
This content is from AI, the data and information provided is for reference only and is not applicable to investment and purchase decisions. If there is any incorrect information, please contact customer service to correct it.